Repertoire Partners LP Buys New Holdings in Integral Ad Science Holding Corp. (NASDAQ:IAS)

Repertoire Partners LP acquired a new position in Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 155,000 shares of the company's stock, valued at approximately $1,676,000. Integral Ad Science makes up about 1.9% of Repertoire Partners LP's investment portfolio, making the stock its 9th largest holding. Repertoire Partners LP owned about 0.10% of Integral Ad Science as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the company. Point72 DIFC Ltd purchased a new position in Integral Ad Science in the third quarter valued at about $41,000. Point72 Asset Management L.P. purchased a new position in Integral Ad Science in the third quarter valued at about $371,000. Invenomic Capital Management LP boosted its stake in Integral Ad Science by 57.4% in the third quarter. Invenomic Capital Management LP now owns 585,309 shares of the company's stock valued at $6,327,000 after acquiring an additional 213,488 shares during the last quarter. Janus Henderson Group PLC boosted its stake in Integral Ad Science by 65.9% in the third quarter. Janus Henderson Group PLC now owns 359,370 shares of the company's stock valued at $3,884,000 after acquiring an additional 142,741 shares during the last quarter. Finally, Centiva Capital LP boosted its stake in Integral Ad Science by 262.9% in the third quarter. Centiva Capital LP now owns 36,881 shares of the company's stock valued at $399,000 after acquiring an additional 26,719 shares during the last quarter. 95.78% of the stock is owned by institutional investors.

Integral Ad Science Stock Down 2.3 %

IAS traded down $0.25 during trading on Thursday, reaching $10.86. The stock had a trading volume of 738,878 shares, compared to its average volume of 1,361,541. Integral Ad Science Holding Corp. has a one year low of $7.98 and a one year high of $17.53. The company has a market capitalization of $1.77 billion, a price-to-earnings ratio of 54.30, a P/E/G ratio of 1.56 and a beta of 1.45. The stock's 50 day moving average is $11.11 and its two-hundred day moving average is $10.61. The company has a current ratio of 3.71, a quick ratio of 3.71 and a debt-to-equity ratio of 0.07.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last released its quarterly earnings data on Tuesday, November 12th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of $0.08 by $0.02. Integral Ad Science had a return on equity of 3.47% and a net margin of 6.39%. The company had revenue of $133.50 million for the quarter, compared to analysts' expectations of $138.06 million. During the same period last year, the firm posted ($0.09) earnings per share. Integral Ad Science's revenue was up 11.0% compared to the same quarter last year. As a group, analysts expect that Integral Ad Science Holding Corp. will post 0.26 earnings per share for the current year.

Insiders Place Their Bets

In other news, CEO Lisa Utzschneider sold 10,481 shares of the firm's stock in a transaction dated Monday, October 7th. The stock was sold at an average price of $10.11, for a total value of $105,962.91. Following the transaction, the chief executive officer now owns 239,709 shares of the company's stock, valued at $2,423,457.99. This trade represents a 4.19 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Tania Secor sold 5,240 shares of the firm's stock in a transaction dated Monday, October 7th. The stock was sold at an average price of $10.11, for a total value of $52,976.40. Following the completion of the transaction, the chief financial officer now directly owns 248,223 shares in the company, valued at $2,509,534.53. This trade represents a 2.07 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 23,006 shares of company stock valued at $240,296. Insiders own 2.00% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on IAS shares. Craig Hallum dropped their price target on shares of Integral Ad Science from $18.00 to $16.00 and set a "buy" rating on the stock in a research note on Wednesday, November 13th. Benchmark restated a "hold" rating on shares of Integral Ad Science in a research note on Thursday, November 14th. Scotiabank began coverage on Integral Ad Science in a research report on Thursday. They set a "sector perform" rating and a $10.00 price target for the company. Oppenheimer cut their price objective on Integral Ad Science from $20.00 to $18.00 and set an "outperform" rating for the company in a report on Wednesday, November 13th. Finally, Piper Sandler cut their price objective on Integral Ad Science from $18.00 to $16.00 and set an "overweight" rating for the company in a report on Wednesday, November 13th. Four equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $15.18.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.